(Q45138879)

English

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 December 2017

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning (English)

1 reference

Europe PubMed Central

9 December 2017

contraindication

1 reference

based on heuristic

inferred from title

Isaac Ben-Bassat

9

object named as

I Ben-Bassat

1 reference

Europe PubMed Central

9 December 2017

author name string

A Shimoni

1

1 reference

Europe PubMed Central

9 December 2017

N Kröger

2

1 reference

Europe PubMed Central

9 December 2017

T Zabelina

3

1 reference

Europe PubMed Central

9 December 2017

F Ayuk

4

1 reference

Europe PubMed Central

9 December 2017

I Hardan

5

1 reference

Europe PubMed Central

9 December 2017

M Yeshurun

6

1 reference

Europe PubMed Central

9 December 2017

N Shem-Tov

7

1 reference

Europe PubMed Central

9 December 2017

A Avigdor

8

1 reference

Europe PubMed Central

9 December 2017

A R Zander

10

1 reference

Europe PubMed Central

9 December 2017

A Nagler

11

1 reference

Europe PubMed Central

9 December 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

9 December 2017

1 reference

Europe PubMed Central

9 December 2017

19

1 reference

Europe PubMed Central

9 December 2017

1

1 reference

Europe PubMed Central

9 December 2017

7-12

1 reference

Europe PubMed Central

9 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403591

0 references

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403591

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403591

1 reference

Europe PubMed Central

9 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45138879&oldid=2066776261"